Lexicon Pharmaceuticals, Inc.
LXRX
$1.62
$0.010.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.01% | -16.59% | -28.66% | -18.12% | -7.90% |
| Total Receivables | 2.14% | 6.92% | -95.40% | 1,266.17% | 19.97% |
| Inventory | 77.85% | -5.95% | -16.42% | -12.99% | -63.68% |
| Prepaid Expenses | -26.56% | 9.63% | 12.26% | -26.77% | -32.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.84% | -15.55% | -40.98% | -0.16% | -8.34% |
|
|
|||||
| Total Current Assets | -16.84% | -15.55% | -40.98% | -0.16% | -8.34% |
| Net Property, Plant & Equipment | -3.25% | 44.03% | -5.26% | -4.95% | 2.38% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 7,880.43% | 0.00% | -55.56% |
| Total Assets | -10.17% | -8.71% | -24.22% | -0.25% | -7.07% |
|
|
|||||
| Total Accounts Payable | -18.80% | -35.63% | -44.81% | -27.78% | 4.23% |
| Total Accrued Expenses | -3.60% | 13.30% | -11.19% | -59.33% | 42.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 279.84% | 80.64% | -97.89% | 3,568.09% | -9.68% |
| Total Finance Division Other Current Liabilities | -- | -75.35% | -61.21% | -- | -- |
| Total Other Current Liabilities | -- | -75.35% | -61.21% | -- | -- |
| Total Current Liabilities | -3.93% | -37.65% | -68.53% | 144.64% | 25.53% |
|
|
|||||
| Total Current Liabilities | -3.93% | -37.65% | -68.53% | 144.64% | 25.53% |
| Long-Term Debt | -12.56% | 0.71% | -4.32% | -41.53% | 0.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 54.55% | -2.65% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 869.46% | -7.50% | 2.17% | -88.69% | 247.42% |
| Total Liabilities | -9.70% | -10.79% | -44.95% | 14.54% | 6.91% |
|
|
|||||
| Common Stock & APIC | 0.14% | 0.16% | 0.15% | 0.14% | 0.07% |
| Retained Earnings | -0.78% | -0.64% | 0.16% | -1.29% | -1.75% |
| Treasury Stock & Other | 0.02% | 0.83% | -0.76% | -14.81% | -5.39% |
| Total Common Equity | -10.50% | -7.17% | 5.21% | -15.70% | -18.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.50% | -7.17% | 5.21% | -15.70% | -18.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.50% | -7.17% | 5.21% | -15.70% | -18.24% |
|
|
|||||